John N. van den Anker
-
- Pharmaceutical studies and practices 59
- Pediatric Pain Management Techniques 17
- Pharmacological Effects and Toxicity Studies 14
- Pharmacology top 0.5%
- Antibiotics Pharmacokinetics and Efficacy 40
- Pharmacogenetics and Drug Metabolism 16
- Pharmacology top 0.2%
- Antibiotics Pharmacokinetics and Efficacy 40
- Pharmacogenetics and Drug Metabolism 16
- Anesthesiology and Pain Medicine top 0.5%
- Anesthesia and Sedative Agents 16
-
- Silicon and Solar Cell Technologies 16
-
- Neonatal and Maternal Infections 13
- Co-authors
- Karel AllegaertJohan W. MoutonDick TibboelMatthijs de HoogNatella RakhmaninaJan LindemansKathleen NevilleIan M. Paul
- Partner nations
- United StatesNetherlandsSwitzerland
In The Last Decade
John N. van den Anker
176 papers receiving 6.5k citations
Hit Papers
Peers
Comparison fields: 5 of 141
- Pediatrics, Perinatology and Child Health 3.6k
- Pharmacology 1.6k
- Pharmacology 782
- Anesthesiology and Pain Medicine 485
- Applied Microbiology and Biotechnology 113
Countries citing papers authored by John N. van den Anker
This map shows the geographic impact of John N. van den Anker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John N. van den Anker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John N. van den Anker more than expected).
Fields of papers citing papers by John N. van den Anker
This network shows the impact of papers produced by John N. van den Anker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John N. van den Anker. The network helps show where John N. van den Anker may publish in the future.
Co-authorship network
The 25 scholars most cited alongside John N. van den Anker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 8 | |
| 2 | 2024 | 5 | |
| 3 | 2022 | 7 | |
| 4 | 2022 | 4 | |
| 5 | 2021 | 17 | |
| 6 | 2019 | 48 | |
| 7 | 2019 | 1 | |
| 8 | 2018 | 13 | |
| 9 | 2017 | 16 | |
| 10 | 2016 | 11 | |
| 11 | 2016 | 5 | |
| 12 | 2015 | 52 | |
| 13 | 2013 | 34 | |
| 14 | 2012 | 55 | |
| 15 | 2011 | 28 | |
| 16 | 2007 | 17 | |
| 17 | Analgesic trials in neonates: observations, pitfalls and recommendations. | 2005 | 2 |
| 18 | 2004 | 14 | |
| 19 | 2003 | 66 | |
| 20 | 2003 | 77 |
About John N. van den Anker
John N. van den Anker is a scholar working on Pediatrics, Perinatology and Child Health, Anesthesiology and Pain Medicine and Pharmacology, having authored 180 papers that have together received 6.7k indexed citations. Recurring topics across this work include Pharmaceutical studies and practices (59 papers), Antibiotics Pharmacokinetics and Efficacy (40 papers), Pediatric Pain Management Techniques (17 papers), Pharmacogenetics and Drug Metabolism (16 papers), Silicon and Solar Cell Technologies (16 papers), Anesthesia and Sedative Agents (16 papers), Pharmacological Effects and Toxicity Studies (14 papers) and Neonatal and Maternal Infections (13 papers). The work is most often cited by research in Pediatrics, Perinatology and Child Health (3.6k citations), Pharmacology (1.6k citations) and Pharmacology (782 citations). John N. van den Anker has collaborated with scholars based in United States, Netherlands and Switzerland. Frequent co-authors include Karel Allegaert, Johan W. Mouton, Dick Tibboel, Matthijs de Hoog, Natella Rakhmanina, Jan Lindemans, Kathleen Neville, Ian M. Paul, Thomas P. Green and Jeffrey L. Galinkin. Their work appears in journals such as JAMA, PEDIATRICS and Advanced Energy Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.